Beijing Institute of Mathematical Sciences and Applications Beijing Institute of Mathematical Sciences and Applications

  • About
    • President
    • Governance
    • Partner Institutions
    • Visit
  • People
    • Management
    • Faculty
    • Postdocs
    • Visiting Scholars
    • Staff
  • Research
    • Research Groups
    • Courses
    • Seminars
  • Join Us
    • Faculty
    • Postdocs
    • Students
  • Events
    • Conferences
    • Workshops
    • Forum
  • Life @ BIMSA
    • Accommodation
    • Transportation
    • Facilities
    • Tour
  • News
    • News
    • Announcement
    • Downloads
About
President
Governance
Partner Institutions
Visit
People
Management
Faculty
Postdocs
Visiting Scholars
Staff
Research
Research Groups
Courses
Seminars
Join Us
Faculty
Postdocs
Students
Events
Conferences
Workshops
Forum
Life @ BIMSA
Accommodation
Transportation
Facilities
Tour
News
News
Announcement
Downloads
Qiuzhen College, Tsinghua University
Yau Mathematical Sciences Center, Tsinghua University (YMSC)
Tsinghua Sanya International  Mathematics Forum (TSIMF)
Shanghai Institute for Mathematics and  Interdisciplinary Sciences (SIMIS)
BIMSA > Seminar on Bioinformatics Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data
Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data
Organizer
Shing Toung Yau
Speaker
Nan Sun
Time
Monday, March 25, 2024 3:30 PM - 4:00 PM
Venue
理科楼A-304
Abstract
Drug screening data from massive bulk gene expression databases can be analyzed to determine the optimal clinical application of cancer drugs. The growing amount of single-cell RNA sequencing (scRNA-seq) data also provides insights into improving therapeutic effectiveness by helping to study the heterogeneity of drug responses for cancer cell subpopulations. Developing computational approaches to predict and interpret cancer drug response in single-cell data collected from clinical samples can be very useful. We propose scDEAL, a deep transfer learning framework for cancer drug response prediction at the single-cell level by integrating large-scale bulk cell-line data. The highlight in scDEAL involves harmonizing drug-related bulk RNA-seq data with scRNA-seq data and transferring the model trained on bulk RNA-seq data to predict drug responses in scRNA-seq. Another feature of scDEAL is the integrated gradient feature interpretation to infer the signature genes of drug resistance mechanisms. We benchmark scDEAL on six scRNA-seq datasets and demonstrate its model interpretability via three case studies focusing on drug response label prediction, gene signature identification, and pseudotime analysis. We believe that scDEAL could help study cell reprogramming, drug selection, and repurposing for improving therapeutic efficacy.
Beijing Institute of Mathematical Sciences and Applications
CONTACT

No. 544, Hefangkou Village Huaibei Town, Huairou District Beijing 101408

北京市怀柔区 河防口村544号
北京雁栖湖应用数学研究院 101408

Tel. 010-60661855
Email. administration@bimsa.cn

Copyright © Beijing Institute of Mathematical Sciences and Applications

京ICP备2022029550号-1

京公网安备11011602001060 京公网安备11011602001060